Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pulse Biosciences CS (PLSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 265,028
  • Shares Outstanding, K 16,870
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,570 K
  • 36-Month Beta 2.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.62 +37.24%
on 03/28/18
22.50 -23.02%
on 04/13/18
+3.80 (+28.11%)
since 03/26/18
3-Month
12.53 +38.23%
on 03/26/18
22.50 -23.02%
on 04/13/18
-4.67 (-21.24%)
since 01/26/18
52-Week
9.81 +76.54%
on 09/13/17
39.50 -56.15%
on 06/20/17
-7.12 (-29.13%)
since 04/26/17

Most Recent Stories

More News
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting

--Dose-response study of clinical and histological effects of NPS energy in human skin wins Best of Basic Science and Translational Research Session Award

PLSE : 17.32 (+10.25%)
Pulse Biosciences Grants Equity Incentive Awards to New Employees

Pulse Biosciences, Inc. (NASDAQ: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today announced...

PLSE : 17.32 (+10.25%)
Pulse Biosciences Quarterly Investor Conference Call

Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform today reports recent...

PLSE : 17.32 (+10.25%)
Pulse Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 16, 2018 / Pulse Biosciences, Inc. (NASDAQ: PLSE) will be discussing their earnings results in their Q4 Earnings Call to be held on March 16, 2018, at 4:30 PM Eastern...

PLSE : 17.32 (+10.25%)
Blog Exposure - Pulse Biosciences Grants Equity Inducement Awards to Its New Employees

Stock Monitor: Lakeland Industries Post Earnings Reporting

PLSE : 17.32 (+10.25%)
LAKE : 13.30 (+1.53%)
Pulse Biosciences Quarterly Investor Conference Call

Pulse Biosciences, Inc. (NASDAQ: PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today reports...

PLSE : 17.32 (+10.25%)
Pulse Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30 PM Eastern...

PLSE : 17.32 (+10.25%)
Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board

Research Desk Line-up: C. R. Bard Post Earnings Coverage

BCR : 331.24 (-0.59%)
PLSE : 17.32 (+10.25%)
ABBV : 97.44 (+6.06%)
Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members

Pulse Biosciences, Inc. (NASDAQ: PLSE), a medical technology company developing proprietary therapeutic tissue treatments based on its Nano (one billionth of a second) Pulse Stimulation (NPS)...

PLSE : 17.32 (+10.25%)
Detailed Research: Economic Perspectives on Discover Financial, Pulse Biosciences, The Travelers Companies, Xylem, Cheniere Energy Partners, and Cheniere Energy - What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Discover Financial Services...

DFS : 72.37 (+0.71%)
CQP : 30.25 (+0.43%)
LNG : 58.82 (+1.76%)
TRV : 132.95 (+0.55%)
XYL : 74.73 (-1.06%)
PLSE : 17.32 (+10.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Key Turning Points

2nd Resistance Point 18.52
1st Resistance Point 17.92
Last Price 17.32
1st Support Level 16.12
2nd Support Level 14.92

See More

52-Week High 39.50
Fibonacci 61.8% 28.16
Fibonacci 50% 24.66
Fibonacci 38.2% 21.15
Last Price 17.32
52-Week Low 9.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar